Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary

NEW YORK (GenomeWeb) – Eurofins Genomics today announced the acquisition of VBC-Biotech's oligonucleotide synthesis and DNA sequencing businesses and the establishment of an Austrian subsidiary.

Eurofins Genomics is the genomics division of the Eurofins Scientific Group. The Austrian subsidiary, called Eurofins Genomics AT and headquartered in Vienna, will leverage Eurofins' global network, production capacity, and infrastructure.

"The new direct presence in Austria will provide value to our customers by demonstration our commitment to this market," Eurofins Genomics AT Managing Director Siegfried Schnabl said in a statement. "Furthermore, Vienna will serve as a perfect hub for future business into Central and Eastern Europe and beyond."

Financial and other terms of the deal were not disclosed.

Earlier this month, Eurofins Genomics established a subsidiary in Milan, Italy by buying the oligonucleotide and DNA sequencing business of Primm.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.